Biofrontera Inc.: A Compelling Investment in Dermatology
October 28, 2025
Biotechnology
-
-
Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
October 23, 2025
-
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
October 16, 2025
-
Dominari Securities Raises Over $1.4 Billion Year-to-Date in Support of American Innovation and Entrepreneurship
October 16, 2025
-
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
October 10, 2025
-
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
October 10, 2025
-
Spruce Biosciences Announces $50.0 Million Private Placement Financing
October 8, 2025
-
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
October 8, 2025
-
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
October 8, 2025
-
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
October 6, 2025
-
Theratechnologies Announces Completion of Acquisition by Future Pak
September 25, 2025
-
Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings
September 25, 2025
-
Renalytix: Transforming Diabetes and Kidney Disease Through Early Risk Prediction
September 12, 2025
-
Biofrontera Inc.: A Compelling Investment in Dermatology
September 9, 2025
-
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 18, 2025
-
FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet’s Disease after Reviewing Recent Phase 2 Clinical Study Results
August 18, 2025